{
  "symbol": "REGN",
  "year": 2022,
  "period": "Y2022",
  "curated_text": "Symbol: REGN. Year: 2022. Period: Y2022. ReportType: K10. Section: Competition and Market Position. This section discusses competitors, market dynamics, and regulatory landscape.  Competitors mentioned: Marketed Products, New Indications, Novartis AG, Genentech/Roche, DME, RVO, Samsung Bioepis Co., Ltd./Biogen Inc., AMD, Genentech/Roche Wet, Genentech/Roche Wet AMD, DME United, RVO Worldwide, 24 Table of Contents Marketed Product, Product Competitor Indication Territory, Allergan/AbbVie Inc. DME, EU, Alimera Sciences, Inc., EU Conbercept Chengdu Kanghong Pharmaceutical Group Co., China Dupixent, Eli Lilly and Company/Incyte Corporation Moderate, LEO Pharma Inc., Japan Tobacco Inc./Torii Pharmaceutical Co.,, Roche/Novartis Asthma, nasal polyps, GSK, AstraZeneca/Amgen Asthma United, pembrolizumab) Merck & Co., Worldwide Opdivo \u00ae, Bristol-Myers Squibb, EU Praluent Repatha \u00ae, Amgen, HoFH Worldwide, Novartis Primary, Genentech/Roche/Chugai Pharmaceutical Co., Ltd. Rheumatoid, Bristol-Myers Squibb Rheumatoid, Pfizer Rheumatoid, Eli Lilly/Incyte Rheumatoid, Gilead Sciences, NV Rheumatoid, VelocImmune, Consolidated Financial Statements, VelociSuite, Product Molecule Territory Patent, JP 4,723,140 Composition, JP 5,273,746 Methods of Treatment June 24, JP 5,216,002 Formulation, JP 5,291,802 Composition, JP, JP 6,306,588 Methods of Treatment, JP 6,353,838 Methods of Treatment September 4, 2033, JP 6,861,630 Methods of Treatment, Libtayo, JP 6,425,730 Composition, JP 5,307,708 Composition, JP 5,805,660 Formulation, Trademark Office, Dupixent, the U.S. Patent and Trademark Office, the Federal Food, Drug and Cosmetic Act. Context excerpt: Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The table below provides an overview of the current competitive landscape for the key products marketed by us and/or our collaborators under our collaboration agreements with them in such products' currently approved indications. The table below is provided for illustrative purposes only and is not exhaustive. For additional information regarding the substantial competition these marketed products face, including potential future competition from product candidates in clinical development, see also",
  "competition_summary": [
    {
      "competitor": "Marketed Products",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "New Indications",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Novartis AG",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Genentech/Roche",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "DME",
      "mentions": 4,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "RVO",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Samsung Bioepis Co.",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Ltd./Biogen Inc.",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "AMD",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Genentech/Roche Wet",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Genentech/Roche Wet AMD",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "DME United",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "RVO Worldwide",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "24 Table of Contents Marketed Product",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Product Competitor Indication Territory",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Allergan/AbbVie Inc. DME",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "EU",
      "mentions": 10,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Alimera Sciences, Inc.",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "EU Conbercept Chengdu Kanghong Pharmaceutical Group Co.",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "China Dupixent",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Eli Lilly and Company/Incyte Corporation Moderate",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "LEO Pharma Inc.",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Japan Tobacco Inc./Torii Pharmaceutical Co.,",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Roche/Novartis Asthma",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "nasal polyps",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "GSK",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "AstraZeneca/Amgen Asthma United",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "pembrolizumab) Merck & Co.",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Worldwide Opdivo \u00ae",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Bristol-Myers Squibb",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "EU Praluent Repatha \u00ae",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Amgen",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "HoFH Worldwide",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Novartis Primary",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Genentech/Roche/Chugai Pharmaceutical Co., Ltd. Rheumatoid",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Bristol-Myers Squibb Rheumatoid",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Pfizer Rheumatoid",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Eli Lilly/Incyte Rheumatoid",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Gilead Sciences",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "NV Rheumatoid",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "VelocImmune",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Consolidated Financial Statements",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "VelociSuite",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Product Molecule Territory Patent",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 4,723,140 Composition",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 5,273,746 Methods of Treatment June 24",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 5,216,002 Formulation",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 5,291,802 Composition",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 6,306,588 Methods of Treatment",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 6,353,838 Methods of Treatment September 4, 2033",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 6,861,630 Methods of Treatment",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Libtayo",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 6,425,730 Composition",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 5,307,708 Composition",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "JP 5,805,660 Formulation",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Trademark Office",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "Dupixent",
      "mentions": 2,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "the U.S. Patent and Trademark Office",
      "mentions": 3,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    },
    {
      "competitor": "the Federal Food, Drug and Cosmetic Act",
      "mentions": 1,
      "context": "Competition We face substantial competition from pharmaceutical, biotechnology, and chemical companies. Our ability to compete depends, to a great extent, on how fast we can develop safe and effective product candidates, complete clinical testing and approval processes, and supply commercial quantities of the product to the market. Competition among products approved for sale is based on efficacy, safety, reliability, availability, price, patent position, and other factors. Marketed Products The"
    }
  ]
}